Filing Details
- Accession Number:
- 0001127602-12-013030
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-03 18:56:08
- Reporting Period:
- 2012-04-01
- Filing Date:
- 2012-04-03
- Accepted Time:
- 2012-04-03 17:56:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 884731 | Ariad Pharmaceuticals Inc | ARIA | Biological Products, (No Disgnostic Substances) (2836) | 223106987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242993 | M Edward Fitzgerald | C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139 | Executive Vp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-04-01 | 13,000 | $0.00 | 173,080 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-04-03 | 5,200 | $16.18 | 167,880 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2012-04-01 | 13,000 | $0.00 | 13,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 26,000 | No | 4 | M | Direct |
Footnotes
- Shares were acquired upon vesting of restricted stock units awarded on April 1, 2011.
- Represents shares sold to satisfy withholding tax requirements. Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.07 to $16.32, inclusive. The reporting person undertakes to provide to ARIAD Pharmaceuticals, Inc. ("ARIAD"), any security holder of ARIAD, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
- Each restricted stock unit represents a right to receive one share of ARIAD common stock.
- Restricted stock units awarded on April 1, 2011 vest as to 33-1/3% of the award on each of April 1, 2012, April 1, 2013, and April 1, 2014.
Billionaire Hedge Funds
